Skip to main content

Luís Gros Subias

Institutions of which they are part

Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Luís Gros Subias

Institutions of which they are part

Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Red Temática de Investigación Cooperativa en Cáncer - RTICC

IP: Josep Sánchez de Toledo Codina
Collaborators: Luís Gros Subias, Pablo Velasco Puyó, Aroa Soriano Fernández, Maria Cristina Díaz de Heredia Rubio, Miguel Segura Ginard, Constantino Sábado Álvarez, Anna Llort Sales, Laura Alonso Garcia, Josep Roma Castanyer
Funding agency: Instituto de Salud Carlos III
Funding: 186750
Reference: RD12/0036/0016
Duration: 01/01/2013 - 30/06/2017

Calidad de vida en pacientes pediátricos afectos de tumores en el Sistema Nervioso Central. Papel modulador del as secuelas y de las estrategias de afrontamiento de los padres

IP: -
Collaborators: Luís Gros Subias, Constantino Sábado Álvarez, Anna Llort Sales
Funding agency: Asociación Española Contra el Cáncer
Funding: 18000
Reference: AECC 6/2008
Duration: 22/01/2009 - 21/01/2011

Identificación de nuevas dianas terapéuticas en el rabdomiosarcoma: efectos de la silenciación de las vías de señalización celular de NOTCH, Hedgehog y RAS en esta neoplasia

IP: -
Collaborators: Luís Gros Subias, Constantino Sábado Álvarez, Josep Roma Castanyer
Funding agency: Asociación Española Contra el Cáncer
Funding: 18000
Reference: AECC_CAT_01_2007
Duration: 21/01/2008 - 20/01/2010

RTICC - Red Temática de Investigación cooperativa de cáncer

IP: Josep Sánchez de Toledo Codina
Collaborators: Luís Gros Subias, Maria Cristina Díaz de Heredia Rubio, Miguel Segura Ginard, Constantino Sábado Álvarez, Anna Llort Sales, Josep Roma Castanyer
Funding agency: Instituto de Salud Carlos III
Funding: 51990
Reference: RD06/0020/1021
Duration: 01/01/2008 - 31/12/2014

Related news

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

A study jointly led by the Hospital Clínic of Barcelona and the Vall d'Hebron Research Institute (VHIR) confirms the effectiveness of neonatal screening in reducing morbidity among children with sickle cell disease (SCD).

Active participation by patients and families in studies helps identify more effective therapies that improve quality of life and survival.

Related professionals

Melissa Panesso Romero

Melissa Panesso Romero

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Jorge Garcia Valcarcel

Jorge Garcia Valcarcel

Research assistant
Reconstructive Surgery of the Locomotor System
Read more
Ana Belen Gavilan Saccarello

Ana Belen Gavilan Saccarello

Predoctoral researcher
Infectious Diseases
Read more
Cristina Guirao Martinez

Cristina Guirao Martinez

Research technician
Nephrology and kidney transplantation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.